Detecting Specific Cytotoxic T Lymphocytes Against SARS-coronavirus with DimerX HLA-A2:Ig Fusion Protein
Overview
Authors
Affiliations
To assess specific cytotoxic T lymphocytes (CTLs) against Severe acute respiratory syndrome (SARS)-coronavirus, a modified DimerX flow cytometry assay was performed with peripheral blood mononuclear cell (PBMC) from HLA-A2+ SARS-recovered donors at different time points post disease. CD8+DimerX-S1203+ CTLs were detected in the PBMC from these donors up to 3 months after recovery. The percentages of CD8+DimerX-S1203+ cells paralleled the numbers of interferon-gamma-positive spots in an ELISPOT assay using the same antigenic peptide. In conclusion, DimerX-based flow cytometry staining may prove to be a real-time method to screen for CTL directed at epitopes from a newly identified virus.
SARS-CoV-2 infection and stem cells: Interaction and intervention.
Yu F, Jia R, Tang Y, Liu J, Wei B Stem Cell Res. 2020; 46:101859.
PMID: 32570174 PMC: 7263221. DOI: 10.1016/j.scr.2020.101859.
Lv Y, Ruan Z, Wang L, Ni B, Wu Y BMC Immunol. 2009; 10:61.
PMID: 19958537 PMC: 2792222. DOI: 10.1186/1471-2172-10-61.
Yang L, Peng H, Zhu Z, Li G, Huang Z, Zhao Z Clin Immunol. 2006; 120(2):171-8.
PMID: 16781892 PMC: 7106132. DOI: 10.1016/j.clim.2006.05.002.
Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine.
Zhao P, Cao J, Zhao L, Qin Z, Ke J, Pan W Virology. 2004; 331(1):128-35.
PMID: 15582659 PMC: 7111813. DOI: 10.1016/j.virol.2004.10.016.